8PUI

human PHOX2B C-terminal domain including the polyA fragment at 298K

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-13C HSQC	0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	298	Bruker AVANCE NEO 800
2	2D 1H-15N HSQC	0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	298	Bruker AVANCE NEO 800
3	3D 1H-15N NOESY	0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	298	Bruker AVANCE NEO 800
4	3D 1H-13C NOESY aliphatic	0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	298	Bruker AVANCE NEO 800
5	3D 1H-13C NOESY aromatic	0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	298	Bruker AVANCE NEO 800
6	3D H(CCO)NH	0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	298	Bruker AVANCE NEO 800
7	3D HNCO	0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	298	Bruker AVANCE NEO 800
8	3D HN(CO)CA	0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	298	Bruker AVANCE NEO 800
9	3D CBCA(CO)NH	0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	298	Bruker AVANCE NEO 800
10	3D HNCA	0.5 mM [U-100% 13C; U-100% 15N] human PHOX2B, 5 mM potassium phosphate, 10 mM sodium chloride, 2 mM beta-mercaptoethanol, 0.03 % w/v sodium azide, 0.5 mM DSS	90% H2O/10% D2O	10 mM	6.8	AMBIENT atm	298	Bruker AVANCE NEO 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE NEO	800

NMR Refinement
Method	Details	Software
torsion angle dynamics		PROCHECK / PROCHECK-NMR

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	4.1.2	Bruker Biospin
2	chemical shift assignment	NMRFAM-SPARKY	3.190	Lee, W.; Tonelli, M.; Markley, J. L. NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics 2015, 31 (8), 1325-1327. DOI: 10.1093/bioinformatics/btu830.
3	structure calculation	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich
4	refinement	PROCHECK / PROCHECK-NMR		Laskowski, MacArthur, Smith, Jones, Hutchinson, Morris, Moss and Thornton